Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock
- PMID: 14707575
- DOI: 10.1097/01.CCM.0000098859.67006.45
Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock
Abstract
Objective: Zymosan enhances formation of reactive oxygen species, which contributes to the pathophysiology of organ failure during nonseptic shock. Here we have investigated the effects of M40401, a new superoxide dismutase mimetic, on the organ failure associated with nonseptic shock caused by zymosan in rats.
Design: Experimental study.
Setting: Laboratory.
Subjects: Male Sprague-Dawley rats.
Interventions: We investigated the effects of M40401 on the organ failure associated with nonseptic shock caused by zymosan (500 mg/kg, administered intraperitoneally as a suspension in saline) in rats.
Measurements and main results: Organ failure and systemic inflammation in rats were assessed 18 hrs after administration of zymosan and/or M40401 and were monitored for 12 days (for loss of body weight and mortality). Treatment of rats with M40401 (10 mg/kg intraperitoneally, 1 and 6 hrs after zymosan) attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan. M40401 administration also attenuated the lung and intestinal injury (histology) as well as the increase in myeloperoxidase activity and malondialdehyde concentrations caused by zymosan in lung and intestine. Immunohistochemical analysis for nitrotyrosine and for poly(adenosine 5'-diphosphate-ribose) revealed positive staining in lung and intestine from zymosan-treated rats. The degree of staining for nitrotyrosine and poly(adenosine 5'-diphosphate-ribose) was markedly reduced in tissue sections obtained from zymosan-treated rats administered with M40401.
Conclusion: This study provides the first evidence that M40401 attenuates the degree of zymosan-induced nonseptic shock in the rat.
Similar articles
-
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.Crit Care Med. 2004 Feb;32(2):457-66. doi: 10.1097/01.CCM.0000109446.38675.61. Crit Care Med. 2004. PMID: 14758164
-
Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice.Crit Care Med. 2006 Apr;34(4):1168-77. doi: 10.1097/01.CCM.0000207346.56477.E8. Crit Care Med. 2006. PMID: 16484922
-
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.Intensive Care Med. 2002 Jun;28(6):775-88. doi: 10.1007/s00134-002-1308-4. Epub 2002 Apr 30. Intensive Care Med. 2002. PMID: 12107686
-
[Induction mechanism of shock: applying the etiology in judgment of the cause of death in forensic practice].Nihon Hoigaku Zasshi. 2004 Sep;58(2):130-40. Nihon Hoigaku Zasshi. 2004. PMID: 15526767 Review. Japanese.
-
Stopping the shock slide.RN. 2002 Sep;65(9):30-4; quiz 35. RN. 2002. PMID: 12365149 Review. No abstract available.
Cited by
-
Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection.Mol Cell Biochem. 2012 Jan;360(1-2):271-7. doi: 10.1007/s11010-011-1066-0. Epub 2011 Oct 1. Mol Cell Biochem. 2012. PMID: 21964536
-
The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock.Intensive Care Med. 2005 May;31(5):693-700. doi: 10.1007/s00134-005-2596-2. Epub 2005 Mar 15. Intensive Care Med. 2005. PMID: 15868139
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials